Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued positive opinions recommending the approval of KEYTRUDA® (pembrolizumab) for two gynecologic cancer indications.…
Takeda (TOKYO:4502/NYSE: TAK) has announced a commitment of JPY 4.6 billion (approximately USD 32 million) to five new Global Corporate Social Responsibility (CSR) partners. This investment is part of Takeda’s ongoing efforts to bolster health system resilience in low- and…
Zoetis Inc., the leading global animal health company, is set to launch its new Vetscan OptiCell™ hematology analyzer, a cutting-edge diagnostic tool that combines cartridge-based technology with AI-powered capabilities for advanced Complete Blood Count (CBC) analysis. Expected to debut in…
Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and sa-mRNA pioneer Arcturus Therapeutics have announced that Japan’s Ministry of Health, Labor and Welfare (MHLW) has approved their updated self-amplifying mRNA (sa-mRNA) COVID-19 vaccine, KOSTAIVE®. This vaccine is designed to protect adults 18…
Oisín Biotechnologies, a privately held company dedicated to addressing age-related diseases, has announced the publication of preclinical data from its follistatin (FST) gene therapy program. The findings, detailed in the article “Safe and Effective Delivery of DNA and RNA Using…
Xencor, Inc. (Nasdaq: XNCR), a clinical-stage biopharmaceutical company focused on developing engineered antibodies for treating cancer and other serious conditions, has announced the launch of an underwritten public offering of its common stock. Certain investors may choose to purchase pre-funded…
enGene Holdings Inc. (Nasdaq: ENGN), a clinical-stage genetic medicines company, announced its financial results for the third quarter ending July 31, 2024, along with a business update. The company’s lead investigational product, detalimogene voraplasmid (formerly known as EG-70), is currently…
AstraZeneca has finalized the studies supporting the regulatory filings for Breztri/Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF) to transition to a new, next-generation propellant. This propellant has a 99.9% lower Global Warming Potential compared to those used in current inhaled medications.…
Stolen contact lenses sold through fake online pharmacies, prescription medications missing active ingredients, and surgical sutures made from substandard materials are just a few examples of counterfeit healthcare products that plague the global market. This illicit industry generates an estimated…
Eli Lilly and Company (NYSE: LLY) and EVA Pharma have announced a new partnership aimed at increasing access to baricitinib for an estimated 20,000 individuals across 49 low- and middle-income countries in Africa by 2030. Developed by Incyte and licensed…
Chugai Pharmaceutical Co., Ltd. [Head Office: Tokyo, President and CEO: Osamu Okuda] and LTL Pharma Co., Ltd. [Head Office: Tokyo, President and Representative Director: Tetsuo Ito] have announced an agreement under which Chugai will transfer its Japanese business related to…
Avanzanite Bioscience BV, a specialty pharmaceutical company in the development stage, has announced that the European Commission (EC) has granted marketing authorization for AKANTIOR® (polihexanide), a treatment for acanthamoeba keratitis (AK) in adults and children aged 12 and older. This…